KEY vs MXCT · P/E 13, rev $7.51B vs rev $38.6M
KeyCorp (KEY) versus MaxCyte Inc (MXCT) — a side-by-side from cached financials, not a winner call.
KeyCorp (KEY) is a banks - regional company listed on US.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
KEY currently screens at market cap $22.64B and trailing P/E 12.8. MXCT currently screens at market cap $124.3M.
Not investment advice. Open the KEY and MXCT stock pages for the full models.
Not investment advice.